IRIS
BAROCELLI, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.683
EU - Europa 9.201
AS - Asia 5.307
SA - Sud America 404
AF - Africa 176
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 5
Totale 25.809
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.429
CN - Cina 2.862
FI - Finlandia 1.917
SE - Svezia 1.718
SG - Singapore 1.704
IE - Irlanda 1.647
IT - Italia 1.139
UA - Ucraina 944
DE - Germania 906
TR - Turchia 430
BR - Brasile 351
GB - Regno Unito 241
CA - Canada 221
IN - India 136
RU - Federazione Russa 135
BE - Belgio 122
CI - Costa d'Avorio 118
FR - Francia 107
AT - Austria 83
RO - Romania 58
CZ - Repubblica Ceca 51
NL - Olanda 34
EU - Europa 32
CM - Camerun 26
ID - Indonesia 21
VN - Vietnam 21
BD - Bangladesh 20
ES - Italia 17
AR - Argentina 16
PA - Panama 14
LT - Lituania 13
HK - Hong Kong 12
MX - Messico 12
KR - Corea 11
MA - Marocco 11
PK - Pakistan 11
EC - Ecuador 10
IQ - Iraq 10
IR - Iran 10
VE - Venezuela 10
AZ - Azerbaigian 9
JP - Giappone 9
PL - Polonia 8
TW - Taiwan 8
CH - Svizzera 7
HU - Ungheria 6
SC - Seychelles 6
CL - Cile 5
CO - Colombia 5
DK - Danimarca 5
EE - Estonia 5
SI - Slovenia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
BG - Bulgaria 4
HR - Croazia 4
LU - Lussemburgo 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AL - Albania 3
DO - Repubblica Dominicana 3
EG - Egitto 3
MD - Moldavia 3
NP - Nepal 3
PH - Filippine 3
PT - Portogallo 3
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
PE - Perù 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
IM - Isola di Man 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LV - Lettonia 1
MC - Monaco 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 25.806
Salva come PNG Salva come JPEG
Città #
Chandler 1.661
Dublin 1.646
Jacksonville 1.109
Singapore 1.047
Santa Clara 972
Ann Arbor 894
Dearborn 768
Beijing 583
Ashburn 497
Boardman 472
Parma 426
Nanjing 422
Izmir 394
Princeton 310
Shanghai 294
New York 234
Wilmington 212
San Mateo 210
Helsinki 172
Toronto 167
Bremen 151
Hebei 133
Kunming 132
Nanchang 132
Shenyang 123
Jinan 121
Abidjan 118
Brussels 118
Moscow 102
Hefei 100
Des Moines 96
Grafing 84
Los Angeles 84
Woodbridge 82
Guangzhou 75
Vienna 75
Tianjin 63
Jiaxing 62
Changsha 59
Seattle 59
Fremont 53
Munich 41
Norwalk 40
Council Bluffs 38
Hangzhou 36
Chicago 34
Auburn Hills 33
Bologna 31
Houston 31
Ottawa 31
Zhengzhou 31
Brno 30
London 30
Marseille 29
Milan 28
Pune 28
Bangalore 27
West Jordan 27
Dallas 26
São Paulo 26
Frankfurt am Main 24
Haikou 24
Kocaeli 23
Jakarta 21
Nuremberg 21
Düsseldorf 20
Fuzhou 20
Redmond 19
Lanzhou 18
Modena 18
Taizhou 18
Brescia 17
Hyderabad 17
Taiyuan 17
Belo Horizonte 16
Chengdu 16
Falkenstein 16
Mestre 16
Ningbo 16
Timisoara 16
Falls Church 15
Redwood City 15
Amsterdam 14
Dong Ket 14
Rio de Janeiro 14
Montegaldella 13
Rome 13
Carpi 12
Montréal 12
Borås 11
Madrid 11
Pesaro 11
Tulsa 10
Baku 9
Chongqing 9
Lubbock 9
Mordano 9
Palermo 9
Leipzig 8
Naples 8
Totale 15.708
Salva come PNG Salva come JPEG
Nome #
1,5-Benzodiazepines Part XIII. Substututed 4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines and 4H-imidazo-[1,2-a][ 1,5]benzodiazepin-5-amines as analgesic, anti-inflammatory and/or antipyretic agents with low acute toxicity 265
1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists 218
1,5-Benzodiazepin tricyclic derivatives as analgersic, anti-inflammatory and /or antipyretic agents with very low acute gastrolesivity and toxicity 209
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 209
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 174
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 171
1,8-Naphthyridines V. Novel N-substituted 5-amino-N,N-diethyl-9-isopropyl [1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamides, as potent anti-inflammatory and/or analgesic agents completely devoid of acute gastrolesivity 161
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 160
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 160
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. 147
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 140
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 136
Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador 135
3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats 134
Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation 128
2-Aminobenzimidazoles as new potent H3-antagonists 127
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 127
Protective Effects of a Protease Inhibitor (Gabexate Mesilate) on Intestinal Ischemia/Reperfusion Injury in Rats 126
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 126
Antinociceptive and gastroprotective effects of inhaled and orally administered Lavandula hybrida Reverchon “Grosso” essential oil 123
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 122
Caratterizzazione farmacologica in vitro di nuovi agonisti muscarinici analoghi dell'Oxotremorina 121
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation 121
Analgesic properties of benzisothiazole/ benzimidazole derivatives with acidic groups 118
Azionifarmacologiche di composti alchilaminoalchilfenilbenzisotiazolici sul trattogastrointestinale 117
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 117
Comparison of the effects of structurally different H2-antagonists on acid and pepsin activity stimulated by dimaprit in conscious cats 116
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 116
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 116
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach 114
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 114
Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system. 113
1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity. 113
The anti-H1-histaminic and antimuscarinic effect of 2- and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds]. 111
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 111
2,4-Substituted benzopyrano[4,3-d]pyrimidines and benzopyrano[4,3-d]pyrimidin-5-ones: synthesis and antiplatelet activity 109
Adaptive changes in rat ileum motility induced by mild mesenteric ischemia/reperfusion injury: role of endogenous mediators and reperfusion time 109
Nuovi potenti agonisti muscarinici oxotremorina-M simili a struttura acetilenica: studio funzionale in vitro 109
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 108
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 107
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 106
[Experimental tracheal transplantation. Literature review and proposal of an original surgical technique]. 106
1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity. 106
Inflammatory proteases released in a mouse model of intestinal ischemia 105
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 105
Structure–Activity Relationships and Mechanism of Action of Eph–ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor 105
Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusioni injury 105
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 105
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 104
2-Amino-1,2-benzisothiazolin-3-one derivatives as powerful antiplatelet agents 104
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 103
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 103
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 103
4-(1,2-benzisothiazol-3-)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities 102
Design and structure-activity relationship of amino acid derivatives of lithocholic acid as novel EphA2 antagonists 102
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 101
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 101
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 101
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 101
Aminobenzimidazoles as new potent H3-antagonists 101
Regional differences in motor responsiveness to antimuscarinic drugs in rabbit isolated small and large intestine 100
Perturbation of The EphA2-EphrinA1 System in Human Prostate Cancer Cells by Colonic (Poly)phenol Catabolites 100
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 99
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 99
Analgesici-antipiretici benzopirano pirimidinici non acidici attivi per via orale privi di gastrolesività 99
R-a-methylhistamine-induced inhibition of gastric acid secretion in pylorus-ligated rats via central histamine H3 receptors 99
Influence of adenosine in the systemic and local injury caused by mesenteric ischemia-reperfusion in mice 98
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 98
The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells 97
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor. 97
A New Potent and Selective Histamine H3-Receptor Antagonist, 4(5)-{2-[4(5)-cyclohexylimidazol-2-ylthio]ethyl}imidazole 96
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 95
Discovery and development of small molecules targeting Eph-ephrin system in glioblastoma: an academic history 95
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 95
Hake fish bone as a calcium source for efficient bone mineralization 94
Mesenteric ischemia-reperfusion: an overview of preclinical drug strategies 94
Rifaximin anti-inflammatory activity on bovine endometrium primary cell cultures: a preliminary study 94
Motor responses of rat hypertrophic intestine following chronic obstruction 94
Discovery and development of Eph-ephrin antagonists endowed with antiangiogenic properties 94
Development of 3-oxo-cholenic derivatives as Eph antagonists able to block in vitro angiogenesis 94
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 93
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 93
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 92
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 92
Antinociceptive affects of inhalated and orally administered Lavandula hybrida Reverchon "Grosso" essential oil 91
Assessment of intestinal motor responsiveness in an ischemia/reperfusion model in rats 91
Bitter taste receptors (T2Rs) expression and regulation in the gastrointestinal tract in mice. 91
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 91
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 91
Eph-ephrin antagonism in tumor angiogenesis and growth: UniPR1331 preclinical evidence. 91
Novel antiplatelet and antithrombotic activities of essential oil from Lavandula hybrida Reverchon "Grosso" 90
Different role of the Histamine H3 Receptor in Vagal-, Betanechol-, Pentagastrin-induced Gastric Acid Secretion in Anaesthetized Rats 90
Antiulcer long-term treatment in chronic ulcer rat 90
Biochemical platform for the identification of adverse effects triggered by free hemoglobin in guinea pigs 90
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 90
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 90
Discovery of natural extracts interfering with EphA2-ephrinA1 system 90
NEW EPH ANTAGONISTS DISCRIMINATING BETWEEN EPH-AS AND EPH-BS CLASSES 89
Activation of proteinase-activated receptor 2 prevents gastrointestinal transit delay induced by ischemia/reperfusion in rats 89
Design and structure-activity relationships of amino acid derivatives of lithocholic acid as novel EphA2 receptor antagonists. 89
Totale 11.271
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.292
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020719 0 0 0 0 0 0 0 0 0 292 160 267
2020/20212.297 44 265 205 72 305 109 279 50 458 96 336 78
2021/20221.869 64 57 53 239 117 126 199 213 71 125 116 489
2022/20236.474 760 675 390 473 646 725 111 361 1.997 57 199 80
2023/20242.213 128 194 59 88 168 565 211 119 85 111 160 325
2024/20254.611 229 397 514 411 723 870 281 353 817 16 0 0
Totale 26.136